Non classé
DiCE Attends The Horizon Europe Cancer Mission ‘Diagnosis and Treatment’ Cluster Meeting
On September 12th in sunny Barcelona, DiCE, a member of the SAGITTARIUS EU Project, participated in the Horizon Europe Cancer Mission’s ‘Diagno...
Rising Liver Cancer Mortality in Europe Linked to Hepatitis B and C Infections Amidst Variance in Prevention and Treatment
Primary liver cancer is the sixth most common cause of cancer-related deaths in Europe. Infection with hepatitis B or C is one of the main risk fac...
DiCE’s Report from the AMMF Annual Cholangiocarcinoma Conference
The Alan Moremont Memorial Fund (AMMF) is the UK’s Cholangiocarcinoma charity. Its annual conference brings together UK and international experts...
DiCE Elevates Patient Advocacy Skills at WECAN Academy in Barcelona
Digestive Cancers Europe (DiCE) had the incredible opportunity to attend the WECAN Academy in the sunny city of Barcelona. Our goal at DiCE is to e...
PerMICCion: A Study on Transforming Colorectal Cancer Prevention and Treatment through Gut Microbiome Research
A groundbreaking study in Germany, known as PerMICCion, is investigating how understanding the microorganisms in our gut, known as the gut microbio...
Do You Want to Have a Say in which Treatments Will Be Available in EU Countries? Get involved in EU HTA
HTA Regulation will involve patients in joint technology assessments at the EU level for oncology treatments. This will utilise patients’ kno...
Reflecting on a Milestone: The Successful Romanian Policy Event on Digestive Cancers
June 2, 2024 – The recent Romanian policy event on digestive cancers, held on May 28, has left us with a sense of profound accomplishment and...
United Against Pancreatic Cancer: A Call to Action Ahead of the 2024 EU Elections
In anticipation of the upcoming 2024 EU Elections, we are supporting Pancreatic Cancer Europe’s (PCE) initiative to turn the tide against pan...
DiCE Highlights the Need for Timely Access to Medicines at the 20th Biosimilars Conference in Amsterdam
We were glad to contribute to the discussions on the best ways to future-proof access to the next wave of cancer medicines. DiCE participated in a ...
DiCE’s Report from the EASL Liver Cancer Summit
The EASL | The Home of Hepatology Liver Cancer Summit took place in Rotterdam, The Netherlands, from 22 – 24 February. This annual meeting i...
